Truvada PrEP: Why I voted "Yes"

Annals of Internal Medicine

Volumn 157, Issue 7, 2012, Pages 521-522

  Feinberg, Judith ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; DRUG EFFICACY; DRUG TOLERANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; MALE HOMOSEXUAL; NOTE; PREEXPOSURE PROPHYLAXIS; PRIORITY JOURNAL; VERTICAL TRANSMISSION;

EID: 84868324648     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-157-7-201210020-00513     Document Type: Note

References (8)

1. Sperling RS, Shapiro DE, Coombs RW, Todd JA, Herman SA, McSherry GD, et al. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 1996;335: 1621-9. [PMID: 8965861]
2. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med. 2000;342: 921-9. [PMID: 10738050]
3. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al; HPTN 052 Study Team. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365:493-505. [PMID:21767103]
4. Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al; iPrEx Study Team. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363:2587-99. [PMID: 21091279]
5. Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, et al; the Partners PrEP Study Team. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012. [PMID: 22784037]
6. Van Damme L, Corneli A, Ahmed K, Agot K, Lombaard J, Kapiga S, et al; FEM-PrEP Study Group. The FEM-PrEP trial of emtricitabine/tenofovir disoproxil fumarate (Truvada) among African women [Abstract]. Presented at the 19th Conference on Retroviruses and Opportunistic Infections, Seattle, 5-8 March 2012. Abstract 32LB.
7. U.S. Department of Health and Human Services. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. Washington, DC: U.S. Department of Health and Human Services; 2012.
8. Karim SS, Karim QA. Antiretroviral prophylaxis for HIV prevention reaches a key milestone [Letter]. Lancet. 2012;379:2047-8. [PMID: 22608193]